ADMA Biologics Inc (ADMA) — Cash Flow-to-Debt Ratio
ADMA Biologics Inc (ADMA) has a Cash Flow-to-Debt Ratio of 0.21x as of March 2026, meaning its operating cash flow of $58.25 Million could theoretically repay 0% of its total liabilities ($274.86 Million) in one year. See ADMA Biologics Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
ADMA Biologics Inc Cash Flow-to-Debt Ratio (2006–2025)
Historical debt coverage capacity for ADMA Biologics Inc across 20 annual periods. Also explore how fast is ADMA Biologics Inc growing its equity to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for ADMA Biologics Inc (2006–2025)
Year-by-year debt coverage analysis for ADMA Biologics Inc. For market capitalisation and broader financial context, see ADMA Biologics Inc market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.34x | $50.40 Million | $146.92 Million | ▼ -59.6% |
| 2024 | 0.85x | $118.67 Million | $139.66 Million | ▲ +1773.0% |
| 2023 | 0.05x | $8.80 Million | $193.98 Million | ▲ +115.0% |
| 2022 | -0.30x | $-59.51 Million | $196.49 Million | ▲ +63.6% |
| 2021 | -0.83x | $-112.37 Million | $135.08 Million | ▲ +2.6% |
| 2020 | -0.85x | $-102.00 Million | $119.42 Million | ▼ -13.1% |
| 2019 | -0.76x | $-76.19 Million | $100.90 Million | ▲ +16.7% |
| 2018 | -0.91x | $-62.68 Million | $69.11 Million | ▼ -64.7% |
| 2017 | -0.55x | $-37.27 Million | $67.69 Million | ▲ +15.2% |
| 2016 | -0.65x | $-18.27 Million | $28.14 Million | ▲ +3.6% |
| 2015 | -0.67x | $-15.42 Million | $22.89 Million | ▲ +2.8% |
| 2014 | -0.69x | $-14.70 Million | $21.22 Million | ▲ +33.8% |
| 2013 | -1.05x | $-10.89 Million | $10.41 Million | ▲ +7.1% |
| 2012 | -1.13x | $-6.90 Million | $6.13 Million | ▲ +79.4% |
| 2011 | -5.47x | $-29.00K | $5.31K | ▼ -243.3% |
| 2010 | -1.59x | $-19.68K | $12.36K | ▲ +43.4% |
| 2009 | -2.82x | $-24.46 Million | $8.69 Million | ▲ +60.8% |
| 2008 | -7.18x | $-19.00 Million | $2.65 Million | ▼ -345.5% |
| 2007 | -1.61x | $-23.61 Million | $14.65 Million | ▲ +0.0% |
| 2006 | -1.61x | $-23.61 Million | $14.65 Million | — |